Vulvar cancer is a sporadic type of cancer which forms in a woman's external genitals, called the vulva. The cancer habitually grows slowly over several years. Firstly, precancerous cells grow on vulvar skin. This is called vulvar intraepithelial neoplasia (VIN), or dysplasia. Not all VIN cases turn into cancer, but it is best to treat it early. There are different types of vulvar cancer i.e Squamous cell carcinomas, Adenocarcinoma, Melanoma, Sarcoma, Basal cell carcinoma.
Disease Statistics: In 2015, around 2,200 women were diagnosed with vulval cancer, approximately 5 everyday. Vulval cancer accounts for around 6% of all gynaecological cancers diagnosed in the UK each year. Incidence of vulval cancer increases with age, with rates increasing sharply from age 65-69. 40% of vulval cancer cases each year in the UK are linked to major lifestyle and other risk factors. A woman’s risk of developing vulval cancer depends on many factors, including age,genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
Treatment: Depending on the nature and stage of the vulvar cancer, a person may need one type of treatment. The 3 main types of treatment used for patients with vulvar cancer are
• Surgery can be Laser surgery, Excision, Vulvectomy
• Radiation therapy
Research: Researcher at Cancer Research UK, study ethical and safety reasons for the drugs developed for this cance. Experimental treatments must be tested in the laboratory before they can be tried in patients. Sentinel lymph node mapping, Ultrasound scan of the groin, HPV tests, HPV vaccines, Anti viral creams and gels for VIN, Photodynamic therapy.